< Back to latest news & events

Event

The Business of Science Conference 2021

September 2021

Event date: 7th October 2021

HGF is sponsoring The Business of Science Conference 2021 on 7th October.

Science and the commercialisation of science continues to be fundamental to the economic growth of the UK and its economy. The Business of Science conference will be held in Birmingham in 2021 to highlight that this city and the wider region has a successful role in the development of ground-breaking science, innovation and invention.

HGF Partner Andy Camenisch will be speaking on ‘Is your IP fit for investment‘. Partners Dr Andrew Wells, Dr Chris Moore, Marie McMorrow and Senior Patent Attorney Dr Janine Swarbrick will also be attending the event.

Find out more

 

Attendees

Andrew
Wells

Marie
McMorrow

Andrew
Camenisch

Latest updates

PRESS RELEASE - HGF secures private equity investment.

HGF secures private equity investment to propel its vision of being Europe’s IP Firm of Choice; to  attract top talent and to deliver excellence to clients. Over the past 30 …

Read article

Managing IP Rising Stars 2024

We are delighted to announce that 12 of our esteemed attorneys have been listed in the 2024 Managing Intellectual Property (MIP) Rising Stars guide! This prestigious recognition highlights the best …

Read article
Event - 15th - 16th October 2024

LSPN North America Fall 2024

HGF are proud to be platinum sponsors of LSPN North America Fall 2024. This year’s event will be held in San Francisco on Tuesday 15th and Wednesday 16th of October …

Event details

Agritech Thymes: Exploring the Agritech IP landscape – past trends and future insights

The agrifood patent landscape analysis recently reported by WIPO provides interesting insights into key areas of innovation and the IP strategies being adopted. The agrifood industry, encompassing both agritech and …

Read article

The Patent Lawyer: UPC’s first year: emergence of a purely civil law system?

The UPC passed its milestone 1 year anniversary on 1 June 2024. At the time of writing we are still awaiting the first substantive decisions on invalidity and infringement, there …

Read article

NK Cell Therapy – an IP update

Advances in CAR-T cell therapy have carved a path for improved treatments in the field of oncology, in particular haematological cancers. In 2018, the European Medicine’s Agency approved the first …

Read article
See all updates